Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA‐Seq
Advanced Science · 2023-05 · 10 (15)
DOI: 10.1002/advs.202205525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 30.03.2023. Verfasst von Meng Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Stem Cells and Tissue Engineering, Sun Yat-Sen University, Ministry of Education, 510080, Guangzhou, China. Hauptthemen laut MEDLINE: Meningioma, Meningeal Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
High‐grade meningioma has an unsatisfactory outcome despite surgery and postoperative radiotherapy; however, the factors driving its malignancy and recurrence remain largely unknown, which limits the development of systemic treatments. Single‐cell RNA sequencing (scRNA‐Seq) technology is a powerful tool for studying intratumoral cellular heterogeneity and revealing the roles of various cell types in oncogenesis. In this study, scRNA‐Seq is used to identify a unique initiating cell subpopulation (SULT1E1 + ) in high‐grade meningiomas. This subpopulation modulates the polarization of M2‐type macrophages and promotes meningioma progression and recurrence. A novel patient‐derived meningioma organoid (MO) model is established to characterize this unique subpopulation. The resulting MOs fully retain the aggressiveness of SULT1E1 + and exhibit invasiveness in the brain after orthotopic transplantation. By targeting SULT1E1 + in MOs, the synthetic compound SRT1720 is identified as a potential agent for systemic treatment and radiation sensitization. These findings shed light on the mechanism underlying the malignancy of high‐grade meningiomas and provide a novel therapeutic target for refractory high‐grade meningioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Stem Cells and Tissue Engineering, Sun Yat-Sen University, Ministry of Education, 510080, Guangzhou, China.
- Medical Research Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, 510080, Guangzhou, China.
- Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
- Department of Neurosurgery in Xiangya Hospital, Central South University, 410008, Changsha, China.
- Department of Pathology in Xiangya Hospital, Central South University, Changsha, 410008, China.
- Department of Neurosurgery, Hunan Children's Hospital, Changsha, 410007, China.
ORCID-Profile: Meng Huang, Wei Zhao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Huang, M., Xu, S., Li, Y., Shang, L., Zhan, X., Qin, C., Su, J., Zhao, Z., He, Y., Qin, L., Zhao, W., Long, W., & Liu, Q. (2023). Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA‐Seq. Advanced Science, 10(15). https://doi.org/10.1002/advs.202205525
Vancouver
Huang M, Xu S, Li Y, Shang L, Zhan X, Qin C, et al. Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA‐Seq. Advanced Science. 2023;10(15). doi:10.1002/advs.202205525
BibTeX
@article{Huang2023,
author = {Huang, Meng and Xu, Shao and Li, Yuzhe and Shang, Li and Zhan, Xiudan and Qin, Chaoyin and Su, Jun and Zhao, Zijin and He, Yi and Qin, Lina and Zhao, Wei and Long, Wenyong and Liu, Qing},
title = {Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA‐Seq},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {15},
doi = {10.1002/advs.202205525}
}
EUVIMED